Arnold M Baskies has bought ANIX on 4 days since Apr 2019

Dr. Arnold M. Baskies is an independent Director at Anixa Biosciences, Inc. (ANIX), serving since September 2018 (previously August 2016–September 2017), where he chairs the Nominating & Corporate Governance Committee and serves on the Audit and Compensation Committees.( A fellowship-trained surgical oncologist affiliated with Virtua Health Systems (NJ) and Clinical Professor of Surgery at Rowan School of Medicine, he specializes in breast, GI, thyroid, melanoma, and parathyroid cancers, and has co-investigated national breast cancer prevention studies.(

Dr. Baskies earned his B.A. summa cum laude and Phi Beta Kappa membership from Boston University (1971) and M.D. from Boston University School of Medicine (1975), completing surgical residency at Boston Medical Center and fellowship in surgical oncology at the National Cancer Institute.( His career highlights include serving as Chairman of the National Board of Directors of the American Cancer Society (2017), first Board Scientific Officer (2015), and leadership in global cancer control initiatives such as the WHO Global Breast Cancer Initiative; he also chaired the NJ Governor’s Task Force on Cancer (2000–2016).( Recently, as ANIX Director, he purchased 10,000 shares on January 28, 2026, at $3.04 (total direct holdings: 135,000 shares) and 5,000 shares on July 18, 2025, at $3.39.(

Written by Perplexity from public sources.